[1]
|
C. J. Murray and A. D. Lopez, “Global Mortality, Disability, and the Contribution of Risk Factors: Global Burden of Disease Study,” Lancet, Vol. 349, No. 9063, 1997, pp. 1436-1442. doi:10.1016/S0140-6736(96)07495-8
|
[2]
|
L. M. Fabbri, F. Luppi, B. Beghe, et al., “Complex Chronic Comorbidities of COPD,” European Respiratory Journal, Vol. 31, No. 1, 2008, pp. 204-212.
doi:10.1183/09031936.00114307
|
[3]
|
J. D. Maclay, D. A. McAllister and W. Macnee, “Cardiovascular Risk in Chronic Obstructive Pulmonary Disease,” Respirology, Vol. 12, No. 5, 2007, pp. 634-641.
doi:10.1111/j.1440-1843.2007.01136.x
|
[4]
|
D. D. Sin and S. F. Man, “Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality,” Proceedings of the American Thoracic Society, Vol. 2, No. 1, 2005, pp. 8-11.
doi:10.1513/pats.200404-032MS
|
[5]
|
P. M. Calverley, J. A. Anderson, B. Celli, et al., “Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease,” The New England Journal of Medicine, Vol. 356, No. 8, 2007, pp. 775-789.
doi:10.1056/NEJMoa063070
|
[6]
|
R. A. Pauwels, C. G. Lofdahl, L. A. Laitinen, et al., “LongTerm Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking,” The New England Journal of Medicine, Vol. 340, No. 25, 1999, pp. 1948-1953.
doi:10.1056/NEJM199906243402503
|
[7]
|
W. MacNee, “Pathogenesis of Chronic Obstructive Pulmonary Disease,” Proceedings of the American Thoracic Society, Vol. 2, No. 4, 2005, pp. 258-266.
doi:10.1513/pats.200504-045SR
|
[8]
|
H. J. Schunemann, J. Dorn, B. J. Grant, et al., “Pulmonary Function Is a Long-Term Predictor of Mortality in the General Population: 29-Year Follow-Up of the Buffalo Health Study,” Chest, Vol. 118, No. 3, 2000, pp. 656-664. doi:10.1378/chest.118.3.656
|
[9]
|
D. D. Sin, L. Wu and S. F. Man, “The Relationship Between Reduced Lung Function and Cardiovascular Mortality: A Population-Based Study and a Systematic Review of the Literature,” Chest, Vol. 127, No. 6, 2005, pp. 1952-1959. doi:10.1378/chest.127.6.1952
|
[10]
|
S. M. Curkendall, C. DeLuise, J. K. Jones, et al., “Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada Cardiovascular Disease in COPD Patients,” Annals of Epidemiology, Vol. 16, No. 1, 2006, pp. 63-70.
doi:10.1016/j.annepidem.2005.04.008
|
[11]
|
M. Zureik, A. Benetos, C. Neukirch, et al., “Reduced Pulmonary Function Is Associated with Central Arterial Stiffness in Men,” American Journal of Respiratory and Critical Care Medicine, Vol. 164, No. 12, 2001, pp. 2181-2185.
|
[12]
|
E. B. Schroeder, V. L. Welch, G. W. Evans, et al., “Impaired Lung Function and Subclinical Atherosclerosis. The ARIC Study,” Atherosclerosis, Vol. 180, No. 2, 2005, pp. 367-373. doi:10.1016/j.atherosclerosis.2004.12.012
|
[13]
|
D. A. McAllister, J. D. Maclay, N. L. Mills, et al., “Arterial Stiffness Is Independently Associated with Emphysema Severity in Patients with Chronic Obstructive Pulmonary Disease,” American Journal of Respiratory and Critical Care Medicine, Vol. 176, No. 12, 2007, pp. 1208-1214. doi:10.1164/rccm.200707-1080OC
|
[14]
|
H. Iwamoto, A. Yokoyama, Y. Kitahara, et al., “Airflow Limitation in Smokers Is Associated with Subclinical Atherosclerosis,” American Journal of Respiratory and Critical Care Medicine, Vol. 179, No. 1, 2009, pp. 35-40.
doi:10.1164/rccm.200804-560OC
|
[15]
|
A. T. Hirsch, Z. J. Haskal, N. R. Hertzer, et al., “ACC/ AHA 2005 Practice Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop,” Circulation, Vol. 113, No. 11, 2006, pp. e463-e654.
|
[16]
|
M. H. Criqui, J. O. Denenberg, R. D. Langer, et al., “The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk,” Vascular Medicine, Vol. 2, No. 3, 1997, pp. 221-226.
|
[17]
|
J. Ness, W. S. Aronow, “Prevalence of Coexistence of Coronary Artery Disease, Ischemic Stroke, and Peripheral Arterial Disease in Older Persons, Mean Age 80 Years, in an Academic Hospital-Based Geriatrics Practice,” Journal of the American Geriatrics Society, Vol. 47, No. 10, 1999, pp. 1255-1256.
|
[18]
|
J. I. Weitz, J. Byrne, G. P. Clagett, et al., “Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review,” Circulation, Vol. 94, No. 11, 1996, pp. 3026-3049. doi:10.1161/01.CIR.94.11.3026
|
[19]
|
D. R. Jacobs Jr., H. Adachi, I. Mulder, et al., “Cigarette Smoking and Mortality Risk: Twenty-Five-Year FollowUp of the Seven Countries Study,” The Archives of Internal Medicine, Vol. 159, No. 7, 1999, pp. 733-740.
doi:10.1001/archinte.159.7.733
|
[20]
|
K. Nishimura, T. Izumi, M. Tsukino, et al., “Dyspnea Is a Better Predictor of 5-Year Survival than Airway Obstruction in Patients with COPD,” Chest, Vol. 121, No. 5, 2002, pp. 1434-1440. doi:10.1378/chest.121.5.1434
|
[21]
|
American Thoracic Society, “Standardization of Spirometry,” American Journal of Respiratory and Critical Care Medicine, Vol. 152, No. 3, 1995, pp. 1107-1136.
|
[22]
|
D. A. Mahler, C. K. Wells, Evaluation of Clinical Methods for Rating Dyspnea,” Chest, Vol. 93, No. 3, 1988, pp. 580-586. doi:10.1378/chest.93.3.580
|
[23]
|
M. A. Puhan, J. Garcia-Aymerich, M. Frey, et al., “Expansion of the Prognostic Assessment of Patients with Chronic Obstructive Pulmonary Disease: The Updated BODE Index and the ADO Index,” Lancet, Vol. 374, No. 9691, 2009, pp. 704-711.
doi:10.1016/S0140-6736(09)61301-5
|
[24]
|
O. Castagna, A. Boussuges, E. Nussbaum, et al., “Peripheral Arterial Disease: An Underestimated Aetiology of Exercise Intolerance in Chronic Obstructive Pulmonary Disease Patients,” European Journal of Cardiovascular Prevention & Rehabilitation, Vol. 15, No. 3, 2008, pp. 270-277. doi:10.1097/HJR.0b013e3282f009a9
|
[25]
|
T. Fujiwara, S. Saitoh, et al., “Prevalence of Asymptomatic Arteriosclerosis Obliterans and Its Relationship with Risk Factors in Inhabitants of Rural Communities in Japan: Tanno-Sobetsu study,” Atherosclerosis, Vol. 177, No. 1, 2004, pp. 83-88.
|
[26]
|
H. Ohnishi, Y. Sawayama, et al., “Risk Factors for and the Prevalence of Peripheral Arterial Disease and Its Relationship to Carotid Atherosclerosis: The Kyushu and Okinawa Population Study (KOPS),” Journal of Atherosclerosis and Thrombosis, Vol. 30, Vol. 17, 2010, pp. 751758.
|
[27]
|
F. G. Fowkes, G. D. Murray, I. Butcher, et al., “Ankle Brachial Index Combined with Framingham Risk Score to Predict Cardiovascular Events and Mortality: A MetaAnalysis,” Journal of the American Medical Association, Vol. 300, No. 2, 2008, pp. 197-208.
doi:10.1001/jama.300.2.197
|
[28]
|
G. Hartmann, M. Tschop, R. Fischer, et al., “High Altitude Increases Circulating Interleukin-6, Interleukin-1 Receptor Antagonist and C-Reactive Protein,” Cytokine, Vol. 12, No. 3, 2000, pp. 246-252.
doi:10.1006/cyto.1999.0533
|
[29]
|
V. Savransky, A. Nanayakkara, J. Li, et al., “Chronic Intermittent Hypoxia Induces Atherosclerosis,” American Journal of Respiratory and Critical Care Medicine, Vol. 175, No. 12, 2007, pp. 1290-1297.
doi:10.1164/rccm.200612-1771OC
|
[30]
|
G. Engstrom, O. Melander, B. Hedblad, ‘Population-Based Study of Lung Function and Incidence of Heart Failure Hospitalisations,” Thorax, Vol. 65, No. 7, 2010, pp. 633-638. doi:10.1136/thx.2010.135392
|
[31]
|
B. R. Celli, C. G. Cote, J. M. Marin, et al., “The BodyMass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease,” The New England Journal of Medicine, Vol. 350, No. 10, 2004, pp. 1005-1012.
doi:10.1056/NEJMoa021322
|
[32]
|
M. McKenna, S. Wolfson and L. Kuller, “The Ratio of Ankle and Arm Arterial Pressure as an Independent Predictor of Mortality,” Atherosclerosis, Vol. 87, No. 2, 1991, pp. 119-128. doi:10.1016/0021-9150(91)90014-T
|
[33]
|
M. T. Vogt, M. McKenna, S. J. Anderson, et al., “The Relationship between Ankle-Arm Index and Mortality in Older Men and Women,” Journal of the American Geriatrics Society, Vol. 41, No. 5, 1993, pp. 523-530.
|
[34]
|
G. C. Leng, F. G. Fowkes, A. J. Lee, et al., “Use of Ankle Brachial Pressure Index to Predict Cardiovascular Events and Death: A Cohort Study,” British Medical Journal, Vol. 313, No. 7070, 1996, pp. 1440-1444.
doi:10.1136/bmj.313.7070.1440
|
[35]
|
H. E. Resnick, R. S. Lindsay, M. M. McDermott, et al., “Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study,” Circulation, Vol. 109, No. 6, 2004, pp. 733-739. doi:10.1161/01.CIR.0000112642.63927.54
|
[36]
|
R. Schulz, Seeger, et al., “Changes in Extracranial Arteries in Obstructive Sleep Apnoea,” European Respiratory Journal, Vol. 25, No. 1, 2005, pp. 69-74.
|